El deporte como actividad física nos ayuda a mantenernos en forma. Bueno para la salud, cada vez son más las personas que piensan en rutinas con las que conseguir más masa muscular, adelgazar o simplemente liberar el estrés. Un entrenador personal, como profesio …
Beneficios de contratar a un entrenador personal Read More »
En este Short os hablamos de un nuevo tipo de hormigón que podrá usarse para construir hábitats en otros mundos. …
Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that three German-based companies have selected ColoAlert®, the Company’s highly efficacious and easy-to-use screening test for colorectal cancer into their respective corporate health programs.
BioArctic AB announced that its partner Eisai has published an article about long-term health outcomes of anti-amyloid-beta protofibril[1] antibody lecanemab in people living with mild cognitive impairment due to Alzheimer’s disease and mild AD using a disease simulation model in the peer-reviewed journal Neurology and Therapy.
iNtRON Biotechnology has announced that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model.
Spago Nanomedical Hans Arwidsson is proposed as new chairman of the board and Alan Raffensperger is proposed as new board member.
Biovica International Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.
Biovica establishes DiviTum(R) TKa Commercialization Partnership in Italy Read More »
Beactica Therapeutics AB, the Swedish precision oncology company, and Oscotec Inc., the Korean drug development company, announced that they have mutually agreed to terminate their collaboration and licensing agreement.
Beactica Therapeutics and Oscotec mutually agree to conclude oncology collaboration Read More »
RELIEF THERAPEUTICS Holding SA announced it has called an extraordinary general meeting of shareholders to be held at 10:00 a.m. CEST on Friday, April 28, 2023 in Geneva.
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders Read More »
PHC Corporation and NovaScan, Inc. announce the launch of a collaboration through which they will seek to explore the feasibility of MarginScanTM, an investigational “ex vivo” medical device that will seek to support physicians in detecting non-melanoma skin cancers.
